Author Interviews, Cancer Research / 28.01.2025
Roswell Parks Opens Largest Engineering and Cell Manufacturing Facility to Expand Cancer Research
MedicalResearch.com Interview with:
[caption id="attachment_66204" align="alignleft" width="200"]
Dr. Choi[/caption]
Christopher Choi, PhD, MBA
Senior Vice President of Industry Partnerships
Associate Professor of Oncology
Technical Director of GMP Engineering & Cell Manufacturing
Roswell Park Comprehensive Cancer Center
Buffalo, NY
MedicalResearch.com: What is the background for this study? What is a GMP facility?
Response: The opening of the Roswell Park GMP Engineering & Cell Manufacturing Facility (GEM) facility marks a significant milestone in advancing cell and gene therapy research at Roswell Park. Our GMP (Good Manufacturing Practice) facility is a specialized manufacturing space designed to produce cell-based and gene-based products under stringent regulatory conditions to ensure product safety, quality and consistency. These facilities are critical for translating innovative research into clinical-grade products that meet regulatory standards for use in patient care.
The GEM Facility is part of our commitment to driving the next generation of cancer treatments and other advanced therapies, addressing a critical bottleneck in the development of these transformative technologies.
Dr. Choi[/caption]
Christopher Choi, PhD, MBA
Senior Vice President of Industry Partnerships
Associate Professor of Oncology
Technical Director of GMP Engineering & Cell Manufacturing
Roswell Park Comprehensive Cancer Center
Buffalo, NY
MedicalResearch.com: What is the background for this study? What is a GMP facility?
Response: The opening of the Roswell Park GMP Engineering & Cell Manufacturing Facility (GEM) facility marks a significant milestone in advancing cell and gene therapy research at Roswell Park. Our GMP (Good Manufacturing Practice) facility is a specialized manufacturing space designed to produce cell-based and gene-based products under stringent regulatory conditions to ensure product safety, quality and consistency. These facilities are critical for translating innovative research into clinical-grade products that meet regulatory standards for use in patient care.
The GEM Facility is part of our commitment to driving the next generation of cancer treatments and other advanced therapies, addressing a critical bottleneck in the development of these transformative technologies.